Financhill
Back

Utah Medical Products Quote, Financials, Valuation and Earnings

Utah Medical Products Price Quote

$65.96
+0.04 (+-0.5%)
(Updated: April 27, 2024 at 6:26 AM ET)

Utah Medical Products Key Stats

Sell
20
Utah Medical Products (UTMD) is a Sell

Day range:
$65.91 - $67.13
52-week range:
$65.91 - $100.59
Dividend yield:
1.81%
P/E ratio:
14.42
P/S ratio:
4.77
P/B ratio:
1.84%

Volume:
22.5K
Avg. volume:
32.2K
1-year change:
-30.5%
Market cap:
$236.6M
Revenue:
$50.2M
EPS:
$4.57

How Much Does Utah Medical Products Make?

Is Utah Medical Products Growing As A Company?

  • What Is Utah Medical Products's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.09%
  • What Is Utah Medical Products's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.06%

Utah Medical Products Stock Price Performance

What Is Utah Medical Products 52-Week High & Low?

Utah Medical Products Price To Free Cash Flow

Is It Risky To Buy Utah Medical Products?

Is Utah Medical Products Cash Flow Positive?

  • What Is UTMD Cash Flow From Operations?
    Cash flow from operations (TTM) is $22.3M
  • What Is Utah Medical Products’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$4.2M
  • What Is Utah Medical Products’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$639K

Utah Medical Products Return On Invested Capital

  • Is Management Doing A Good Job?
    UTMD return on invested capital is 13.72%
  • What Is Utah Medical Products Return On Assets?
    ROA measures how assets are converting to revenues and is 12.82%
  • What Is UTMD Return On Equity?
    ROE is a measure of profitability and is 13.72%

Utah Medical Products Earnings Date & Stock Price

Utah Medical Products Competitors

  • Who Are Utah Medical Products's Competitors?
    Below is a list of companies who compete with Utah Medical Products or are related in some way:
    • Asensus Surgical Inc (ASXC)
    • Perspective Therapeutics Inc (CATX)
    • Retractable Technologies Inc (RVP)
    • Catheter Precision Inc (VTAK)
    • Xtant Medical Holdings Inc (XTNT)

Utah Medical Products Dividend Yield

Utah Medical Products Analyst Estimates

YoY Growth Past Surprise
EPS: -5.83% -8.99%
Revenue: -9.14% -8.48%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many UTMD shares are owned by institutional investors?
    3.9M UTMD shares are owned by institutional investors
  • How many UTMD shares are owned by insiders?
    100.5K UTMD shares are owned by insiders